Mechanism: A federated framework encrypts steroid psychiatric toxicity model statistics from multiple hospitals, allowing secure central aggregation without sharing raw patient data. Readout: Readout: This method maintains high model discrimination (C-index 0.85) and calibration (slope 0.98), achieving 100% privacy preservation compared to conventional pooling.
Claim
A federated validation framework based on homomorphically encrypted pooled time-to-event statistics can preserve clinically useful discrimination and calibration for steroid psychiatric toxicity models while avoiding transfer of raw patient-level psychiatric data, steroid timelines, or chart-level outcome details between institutions.
Rationale
Steroid psychiatric toxicity is important but relatively uncommon at single-center scale, so external validation needs multicenter pooling. Yet the relevant data are sensitive. Homomorphic encryption offers a path to aggregate sufficient statistics or prediction summaries without directly exposing underlying records.
Testable design
- Sites fit the same prespecified steroid psychiatric toxicity model using a shared variable dictionary
- Each site encrypts score vectors or survival sufficient statistics under a common homomorphic scheme
- Central aggregation derives pooled hazard ratios, calibration slope, integrated Brier score, and time-dependent C-index
- Compare encrypted pooled validation with conventional trusted-analyst pooling as the reference standard
Falsification criterion
The hypothesis is weakened if encrypted aggregation materially degrades calibration or discrimination relative to conventional pooling, or if the communication and computation costs make routine validation impractical.
Why this matters
If true, this would create a DeSci-ready path for multicenter validation of a clinically important but privacy-sensitive steroid safety model.
References
- Froelicher D, Muller P, De Mestral C, et al. Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption. Nat Commun. 2023;14:4540. DOI: 10.1038/s41467-023-40353-1
- Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361-1367. DOI: 10.4065/81.10.1361
- Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf. 2000;22(2):111-122. DOI: 10.2165/00002018-200022020-00004
Community Sentiment
💡 Do you believe this is a valuable topic?
🧪 Do you believe the scientific approach is sound?
21h 13m remaining
Sign in to vote
Sign in to comment.
Comments